-
Mashup Score: 3
Lirentelimab was safe and effective in the long-term treatment of patients with eosinophilic gastritis and/or eosinophilic duodenitis, according to a presentation at UEG Week. “Lirentelimab, previously called AK002, is a humanized monoclonal antibody that targets a receptor called siglec-8 that’s highly specific in eosinophils and mast cells. When this receptor is activated, it
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0
Researchers conducting a clinical trial of treatment for eosinophilic inflammatory diseases of the gastrointestinal tract found an unexpected pool of previously undiagnosed patients, suggesting that current estimates of prevalence of eosinophilic gastritis (EG) and duodenitis (EoD) could be too low.
Source: www.gastroendonews.comCategories: Gastroenterology, Latest HeadlinesTweet-
Current estimates of prevalence of #eosinophilicgastritis and #duodenitis could be too low. https://t.co/5zYKwKSBil @UofUMedicine @AmCollegeGastro @WeillCornell #GERD
-
-
Mashup Score: 0Diagnostic Delay in Patients with Eosinophilic Gastritis and/or Duodenitis: A Population-Based Study - 3 year(s) ago
Eosinophilic gastritis and/or eosinophilic duodenitis (EG/EoD) is characterized by persistent symptoms and elevated eosinophils in the gastrointestinal tract. Limited disease awareness and lack of diagnostic guidelines suggest that patients may remain undiagnosed or endure diagnostic delay.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! Diagnostic Delay in Patients with #Eosinophilic #Gastritis and/or #Duodenitis: A Population-Based Study https://t.co/MKSHady5vB https://t.co/zQE3sEChVp
-
-
Mashup Score: 0Diagnostic Delay in Patients with Eosinophilic Gastritis and/or Duodenitis: A Population-Based Study - 3 year(s) ago
Eosinophilic gastritis and/or eosinophilic duodenitis (EG/EoD) is characterized by persistent symptoms and elevated eosinophils in the gastrointestinal tract. Limited disease awareness and lack of diagnostic guidelines suggest patients may remain undiagnosed or endure diagnostic delay.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! Diagnostic Delay in Patients with #Eosinophilic #Gastritis and/or #Duodenitis: A Population-Based Study https://t.co/MKSHady5vB
-
#ICYMI: #Lirentelimab safe, effective in long-term #gastritis, #duodenitis treatment #UEGWeek #GITwitter #MedTwitter https://t.co/hWrKArWVdp